AB018. Evaluation of nivolumab as second-line treatment in patients with advanced non-small cell lung cancer (NSCLC)

BACKGROUND: Lung cancer has recently emerged as a key objective of immunotherapies. Several patients with advanced lung cancer have benefitted significantly, demonstrating prolonged remissions of the disease and prolongation of survival while the treatment toxicity is reduced. The purpose of the stu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Nikolakopoulou, Asimina, Tzimopoulos, Kon/nos, Kerasiotis, Haralambos, Kallianos, Anastasios, Kavvada, Catherine, Gkartzonika, Helen, Tsarouha, Emilia, Rapti, Angeliki
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2016
Matèries:
Abstract
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5159350/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.AB018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars